Harvard Bioscience Inc (HBIO) stock
HBIONasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 3/3040% above fair value
$9.08+0.17 (+1.91%)
Close on Nov 17, 2026Market cap $41.33MP/E –Yield –
Harvard Bioscience profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Harvard Bioscience's profit margin for the twelve months ending Jun 30, 2026 was -11.9%. For fiscal 2025 it was -65.5%, against -13.2% the year before. The highest annual figure on record is 17.6% in fiscal 2010.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -65.5% | −52.3 |
| FY2024 | Dec 31, 2024 | -13.2% | −10.1 |
| FY2023 | Dec 31, 2023 | -3.0% | +5.4 |
| FY2022 | Dec 31, 2022 | -8.4% | −8.2 |
| FY2021 | Dec 31, 2021 | -0.2% | +7.4 |
| FY2020 | Dec 31, 2020 | -7.6% | −3.6 |
| FY2019 | Dec 31, 2019 | -4.0% | −1.6 |
| FY2018 | Dec 31, 2018 | -2.4% | −1.3 |
| FY2017 | Dec 31, 2017 | -1.1% | +3.0 |
| FY2016 | Dec 31, 2016 | -4.1% | +13.4 |
| FY2015 | Dec 31, 2015 | -17.5% | −19.7 |
| FY2014 | Dec 31, 2014 | 2.2% | +3.9 |
| FY2013 | Dec 31, 2013 | -1.7% | −3.9 |
| FY2012 | Dec 31, 2012 | 2.1% | −1.4 |
| FY2011 | Dec 31, 2011 | 3.5% | −14.1 |
| FY2010 | Dec 31, 2010 | 17.6% | +9.1 |
| FY2009 | Dec 31, 2009 | 8.4% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -12.8% | −1.6 |
| Q1 FY2026 | Mar 31, 2026 | -16.5% | +214.7 |
| Q4 FY2025 | Dec 31, 2025 | -12.0% | −12.1 |
| Q3 FY2025 | Sep 30, 2025 | -6.0% | +15.9 |
| Q2 FY2025 | Jun 30, 2025 | -11.2% | +1.5 |
| Q1 FY2025 | Mar 31, 2025 | -231.2% | −212.0 |
| Q4 FY2024 | Dec 31, 2024 | 0.1% | +6.5 |
| Q3 FY2024 | Sep 30, 2024 | -21.9% | −17.0 |
| Q2 FY2024 | Jun 30, 2024 | -12.7% | −9.3 |
| Q1 FY2024 | Mar 31, 2024 | -19.1% | −21.2 |
| Q4 FY2023 | Dec 31, 2023 | -6.5% | −0.6 |
| Q3 FY2023 | Sep 30, 2023 | -4.9% | +7.8 |
| Q2 FY2023 | Jun 30, 2023 | -3.4% | −11.7 |
| Q1 FY2023 | Mar 31, 2023 | 2.1% | +26.0 |
| Q4 FY2022 | Dec 31, 2022 | -5.9% | −8.8 |
| Q3 FY2022 | Sep 30, 2022 | -12.6% | −12.1 |
| Q2 FY2022 | Jun 30, 2022 | 8.3% | +9.7 |
| Q1 FY2022 | Mar 31, 2022 | -23.9% | −21.4 |
| Q4 FY2021 | Dec 31, 2021 | 2.9% | +4.9 |
| Q3 FY2021 | Sep 30, 2021 | -0.6% | +4.0 |
| Q2 FY2021 | Jun 30, 2021 | -1.4% | +5.4 |
| Q1 FY2021 | Mar 31, 2021 | -2.5% | +16.5 |
| Q4 FY2020 | Dec 31, 2020 | -2.0% | −3.8 |
| Q3 FY2020 | Sep 30, 2020 | -4.6% | +5.0 |
| Q2 FY2020 | Jun 30, 2020 | -6.8% | −5.9 |
| Q1 FY2020 | Mar 31, 2020 | -19.0% | −10.6 |
| Q4 FY2019 | Dec 31, 2019 | 1.8% | −6.7 |
| Q3 FY2019 | Sep 30, 2019 | -9.6% | −8.7 |
| Q2 FY2019 | Jun 30, 2019 | -0.8% | +3.8 |
| Q1 FY2019 | Mar 31, 2019 | -8.4% | +6.8 |
| Q4 FY2018 | Dec 31, 2018 | 8.5% | +3.8 |
| Q3 FY2018 | Sep 30, 2018 | -0.9% | +1.3 |
| Q2 FY2018 | Jun 30, 2018 | -4.6% | −2.6 |
| Q1 FY2018 | Mar 31, 2018 | -15.2% | −9.3 |
| Q4 FY2017 | Dec 31, 2017 | 4.6% | +9.6 |
| Q3 FY2017 | Sep 30, 2017 | -2.2% | +4.3 |
| Q2 FY2017 | Jun 30, 2017 | -2.0% | – |
| Q1 FY2017 | Mar 31, 2017 | -5.9% | – |
| Q4 FY2016 | Dec 31, 2016 | -5.0% | – |
| Q3 FY2016 | Sep 30, 2016 | -6.6% | – |
See a number that looks wrong?